RxDoctor Payments Data

Jason Boudreau

Podiatrist · Milwaukee, WINPI 1518959378

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Stryker at 36.7% of the total. Reporting peaked in 2019 at $1,761 and has fallen 61.3% since, to $682 in 2025.

$5,251in general payments, 2019–2025

Across 83 payments — averaging $63.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Smith+Nephew$792
  • Aroa Biosurgery Incorporated$438
  • Trilliant Surgical LLC.$277
  • Osiris Therapeutics Inc.$262
  • Orthofix Medical, Inc.$188
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$5,251100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,251 in reported general payments places this provider in the 80th percentile of 140 podiatrist providers in Wisconsin.

See all podiatrist providers in Wisconsin

Medicare billing

Part B allowed, 2024
$67,560
Medicare patients
249
Services billed
842

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gentamicin Sulfate43$2,130
Diclofenac Sodium45$1,286
Terbinafine Hcl63$649
Doxycycline Hyclate28$350
Celecoxib24$316
Naproxen31$266
Gabapentin19$234
Ibuprofen15$172
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen21$123
Hydroxyzine Pamoate13$115

Paid to pharmacies, not to this prescriber.

Other podiatrist in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →